# Mirai-MRI breast screening

Source: https://onco.cc/trials/nct07121972/  
OnCo record `nct07121972` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

This study uses an AI risk assessment to select people for additional breast MRI screening. It measures cancer detection rather than testing treatment for an existing cancer.

## Summary

This study uses an AI risk assessment to select people for additional breast MRI screening. It measures cancer detection rather than testing treatment for an existing cancer.

Interventional study registered as NCT07121972, sponsored by University of California, San Francisco. No drug-development phase applies in the structured registry record. Registry enrollment is 400 participants (estimated). Registry status checked October 10, 2026: recruiting. UCSF lists this study as open to eligible people; local availability and overall registry status are separate. See the registry for full eligibility and current sites.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-10-10
- Also known as: Mirai-MRI: Validation of AI Models for Breast Cancer Risk
- Tags: ucsf-breast-coverage; interventional
- Registry id: NCT07121972
- Phase: not-applicable
- Setting: Supplemental MRI screening selected by an AI breast-risk model
- Sponsor: University of California, San Francisco

## Sources

- ClinicalTrials.gov NCT07121972: https://clinicaltrials.gov/study/NCT07121972
- UCSF study listing and local availability: https://clinicaltrials.ucsf.edu/trial/NCT07121972

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- institutions: [UCSF Helen Diller Family Comprehensive Cancer Center](https://onco.cc/institutions/ucsf/)

---
JSON: https://onco.cc/api/v1/entities/nct07121972.json